ARCHIVES

New Biomarker Findings Show Improvement in KRAS Subtype In Phase III Erbitux Trial

This article is from The Cancer Letter archive.

Vol. 37 No. 5 | May 30, 2014

Download PDF Visit The Full Archive

Related Articles

Test May Identify Predictors For Recurrence Post-Surgery

January 28, 2011

Gallo, Rosenberg, Bishop, Varmus Win GM Awards

June 15, 1984

DCE Board Approves Reissuing Epidemiology Small Grants PA

June 3, 1988

Advisors Suggest Consortia For Lung Cancer Research.

November 9, 2001

NCI To Lose 19% of Workforce Over Six Years, Broder Says

November 4, 1994

Panel Recommends 5-FU/Levamisole For Adjuvant Stage 3 Colon Cancer

April 27, 1990